ATA335178A - Verfahren zur herstellung von neuen 1-acyl-2- hydroxy-1,3-diaminopropanen und deren salzen - Google Patents

Verfahren zur herstellung von neuen 1-acyl-2- hydroxy-1,3-diaminopropanen und deren salzen

Info

Publication number
ATA335178A
ATA335178A AT335178A AT335178A ATA335178A AT A335178 A ATA335178 A AT A335178A AT 335178 A AT335178 A AT 335178A AT 335178 A AT335178 A AT 335178A AT A335178 A ATA335178 A AT A335178A
Authority
AT
Austria
Prior art keywords
diaminopropanes
acyl
hydroxy
salts
preparation
Prior art date
Application number
AT335178A
Other languages
English (en)
Other versions
AT357144B (de
Inventor
Hans Dr Liepmann
Rolf Dr Hueschens
Wolfgang Dr Milkowski
Horst Dr Zeugner
Henning Dr Heinemann
Klaus-Ullrich Dr Wolf
Insa Dr Hell
Reinhard Dr Hempel
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772720968 external-priority patent/DE2720968C2/de
Priority claimed from DE2720915A external-priority patent/DE2720915C2/de
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of ATA335178A publication Critical patent/ATA335178A/de
Application granted granted Critical
Publication of AT357144B publication Critical patent/AT357144B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
AT335178A 1977-05-10 1978-05-09 Verfahren zur herstellung von neuen 1-acyl-2- hydroxy-1,3-diaminopropanen und deren salzen AT357144B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19772720968 DE2720968C2 (de) 1977-05-10 1977-05-10 N↓1↓-Acyl-2-hydroxy-1,3-diaminopropane und Arzneimittel
DE2720915A DE2720915C2 (de) 1977-05-10 1977-05-10 N↓1↓-Acyl-2-hydroxy-1,3-diaminopropane und Arzneimittel mit diesen Verbindungen als Wirkstoff

Publications (2)

Publication Number Publication Date
ATA335178A true ATA335178A (de) 1979-11-15
AT357144B AT357144B (de) 1980-06-25

Family

ID=25771998

Family Applications (1)

Application Number Title Priority Date Filing Date
AT335178A AT357144B (de) 1977-05-10 1978-05-09 Verfahren zur herstellung von neuen 1-acyl-2- hydroxy-1,3-diaminopropanen und deren salzen

Country Status (18)

Country Link
US (2) US4191770A (de)
JP (1) JPS53141224A (de)
AT (1) AT357144B (de)
AU (1) AU520625B2 (de)
CH (1) CH636845A5 (de)
DD (1) DD135195A5 (de)
DK (1) DK201878A (de)
ES (1) ES469020A1 (de)
FR (1) FR2390422A1 (de)
GB (1) GB1585758A (de)
IE (1) IE46778B1 (de)
IL (1) IL54677A (de)
IT (1) IT1098213B (de)
NL (1) NL7805038A (de)
NO (1) NO147749C (de)
NZ (1) NZ187221A (de)
PH (1) PH14558A (de)
SU (1) SU906365A3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459235A1 (fr) * 1979-06-14 1981-01-09 Sanofi Sa Nouveaux derives de sulfonyl-aniline, leur procede de preparation et leur application therapeutique
JPS58177953A (ja) * 1982-04-13 1983-10-18 Eisai Co Ltd ポリプレニルカルボン酸アミドおよびその製造方法
US4596813A (en) * 1982-11-04 1986-06-24 Chevron Research Company Pyridylcarbonyl and thiocarbonyl derivatives useful as fungicides
DE69418035T2 (de) * 1993-01-15 1999-08-12 Agouron Pharmaceuticals , Inc., San Diego, Calif. Hiv-proteaseinhibitoren
US5824821A (en) * 1997-02-07 1998-10-20 Nycomed Imaging As Process for the preparation of iodinated contrast agents and intermediates therefor
HUP0004388A3 (en) 1997-11-07 2001-10-29 Upjohn Co Process for the preparation of oxazolidinones, intermediates and preparation thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1805355A (en) * 1929-01-02 1931-05-12 Ig Farbenindustrie Ag Basic compounds and process of preparing them
US2658076A (en) * 1951-06-12 1953-11-03 Searle & Co N-dialkylaminoalkyl derivatives of alpha, beta-diarylalkanoamides and their salts
BE794424A (fr) * 1972-01-24 1973-07-23 Science Union & Cie Nouveaux dibenzocycloheptenes, leur procede d'obtention et leur application comme medicament
DE2265370C2 (de) * 1972-05-03 1982-12-02 Kali-Chemie Ag, 3000 Hannover 6-Phenyl-1,2,3,4-tetrahydro-1,5-benzodiazocinderivate
GB1374366A (en) * 1972-07-21 1974-11-20 Science Union & Cie Propanol derivatives and a process for their preparation
GB1436593A (en) * 1973-03-15 1976-05-19 Science Union & Cie N-substituted acetamides processes for their preparation and pharmaceutical compositions containing them apparatus for processing photograp
DE2314993A1 (de) * 1973-03-26 1974-10-03 Kali Chemie Pharma Gmbh Neue benzodiazepinderivate und verfahren zu deren herstellung
US4141987A (en) * 1974-06-05 1979-02-27 Imperial Chemical Industries Limited 1-Aryloxy-3-thenamidoalkylamino-2-propanol derivatives
DE2448259A1 (de) * 1974-10-10 1976-04-22 Kali Chemie Pharma Gmbh Verfahren zur herstellung von 2-halogenmethyl-1,4-benzodiazepinen
US4144343A (en) * 1978-01-04 1979-03-13 Merck & Co., Inc. Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines

Also Published As

Publication number Publication date
GB1585758A (en) 1981-03-11
IT1098213B (it) 1985-09-07
NO147749B (no) 1983-02-28
FR2390422B1 (de) 1980-07-18
DK201878A (da) 1979-02-14
NZ187221A (en) 1980-12-19
US4402981A (en) 1983-09-06
IL54677A0 (en) 1978-07-31
DD135195A5 (de) 1979-04-18
AU520625B2 (en) 1982-02-11
ES469020A1 (es) 1979-09-01
US4191770A (en) 1980-03-04
NO147749C (no) 1983-06-08
FR2390422A1 (fr) 1978-12-08
NO781631L (no) 1978-11-13
IE780921L (en) 1978-11-10
IE46778B1 (en) 1983-09-21
SU906365A3 (ru) 1982-02-15
NL7805038A (nl) 1978-11-14
AU3594178A (en) 1979-11-15
IT7823159A0 (it) 1978-05-09
JPS6252740B2 (de) 1987-11-06
CH636845A5 (de) 1983-06-30
IL54677A (en) 1981-02-27
JPS53141224A (en) 1978-12-08
AT357144B (de) 1980-06-25
PH14558A (en) 1981-09-24

Similar Documents

Publication Publication Date Title
ATA800876A (de) Verfahren zur herstellung von neuen 2-phenyl-3- aroylbenzothiophenen und 2-phenyl-3- -aroylbenzothiophen-1-oxiden und von deren salzen
AT379811B (de) Verfahren zur herstellung von neuen chinolinen, chinoxalinen und chinazolinen und deren pharmazeutisch verwendbaren derivaten
AT350569B (de) Verfahren zur herstellung von neuen 2- piperidinoalkyl-(1-benzofuranen, 1,4-benzo- dioxanen oder 1,4-benzoxathianen) und deren salzen
AT363491B (de) Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen
DD134099A5 (de) Verfahren zur herstellung von d,1-5-methyltetrahydrofolsaeure und deren salzen
AT347952B (de) Verfahren zur herstellung von neuen 1,1,1- triarylalkylaminen und deren salzen
AT360972B (de) Verfahren zur herstellung von neuen amino- benzoesaeureamiden und deren salzen
AT351025B (de) Verfahren zur herstellung von neuen 1,4-dihydro -pyridinen und deren salzen
AT352137B (de) Verfahren zur herstellung von neuen piperazinylbenzopyron-derivaten und deren salzen
ATA335178A (de) Verfahren zur herstellung von neuen 1-acyl-2- hydroxy-1,3-diaminopropanen und deren salzen
AT359474B (de) Verfahren zur herstellung von neuen 5-phenoxy- 6,7,8,9-tetrahydro-cyclohepten-7-aminen und von deren saeureadditionssalzen
AT359070B (de) Verfahren zur herstellung von neuen 2,4-diamino -5-benzylpyrimidinen und deren salzen
ATA985075A (de) Verfahren zur herstellung von neuen polysubstituierten 10-piperazinodibenzo/b,f/tiepinderivaten und von deren salzen
ATA559778A (de) Verfahren zur herstellung von neuen 1,2- -benzisothiazolen und deren saeureadditions- salzen
AT358588B (de) Verfahren zur herstellung von neuen 1,2,3,4- -tetrahydroisochinolinen und deren salzen
AT352735B (de) Verfahren zur herstellung von neuen 2,4- diamino-5-benzylpyrimidinen und deren saeure- additionssalzen
PT65438A (de) Verfahren zur herstellung des neuen l-benzoyl-2-(2',6'-dichlorphenylamino)-2-imidazolin und von dessen salzen
ATA296479A (de) Verfahren zur herstellung von neuen (1,2- dihydro-2-oxo-nicotinamido)-alkylbenzolsul- fonylharnstoffen und von deren salzen
ATA296379A (de) Verfahren zur herstellung von neuen (1,2- dihydro-2-oxo-nicotinamido)-alkylbenzolsul- fonylharnstoffen und von deren salzen
ATA773277A (de) Verfahren zur herstellung von neuen azolyl-9,10 -dihydroanthracen-derivaten und deren salzen
AT356293B (de) Verfahren zur herstellung von neuen d-6-alkyl-8 -zyanmethylergolinen-i und deren salzen
AT360040B (de) Verfahren zur herstellung von substituierten orotsaeuren, dihydroorotsaeuren und deren salzen
ATA678478A (de) Verfahren zur herstellung von neuen 4-alkyl-3,5-dioxo-pyrazolidinylderivaten und von deren salzen
AT350520B (de) Verfahren zur herstellung von neuen 7-amino- methyl-5,6,7-trihydro-2-substituierten-benzo- cyclohept-8-enen sowie deren saeureadditions- salzen
ATA440579A (de) Verfahren zur herstellung von neuen 3-amino- methyl-4beta-hydroxy-2,9-dioxatricyclo(4,3,1, 03,7)decanen und deren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee